Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Making Pharmaceutical Markets More Competitive Act
Client: ARIZONA HOSPITAL AND HEALTHCARE ASSOCIATION · Firm: BALLARD SPAHR LLP
CMS approval of proposed amendment to Arizona Health Care Cost Containment System's 1115 Research and Demonstration Waiver, which seeks an exemption from the Institutions for Mental Diseases exclusion for all beneficiaries ages 21-64, regardless of delivery system.
Making Pharmaceutical Markets More Competitive Act
Client: ARIZONA HOSPITAL AND HEALTHCARE ASSOCIATION · Firm: BALLARD SPAHR LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ARIZONA HOSPITAL AND HEALTHCARE ASSOCIATION via BALLARD SPAHR LLP
2017 · first_quarter · RR
CMS approval of proposed amendment to Arizona Health Care Cost Containment System's 1115 Research and Demonstration Waiver, which seeks an exemption from the Institutions for Mental Diseases exclusion for all beneficiaries ages 21-64, regardless of delivery system.
CMS approval of proposed amendment to Arizona Health Care Cost Containment System's 1115 Research and Demonstration Waiver, which seeks an exemption from the Institutions for Mental Diseases exclusion for all beneficiaries ages 21-64, regardless of delivery system.
Source: Senate LDA
CMS approval of proposed amendment to Arizona Health Care Cost Containment System's 1115 Research and Demonstration Waiver, which seeks an exemption from the Institutions for Mental Diseases exclusion for all beneficiaries ages 21-64, regardless of delivery system.